Printer-friendly versionIntelectual property rights: The varios views
Intelectual property rights: The varios views
|
Indian government"s concerns with theDunkel draft |
Commerce ministry"s comments: | What the critics say: |
|
If the facility for process palents, currently enjoyedby Indian drug manufacturers, is taken away,prices of several medicines patented by MNCs will soar. |
The magnitude of the price rise will depend on a variety of factors. in any case, medicines Whose product patents are held by MNCs account for only 10 per cent of 10101 drug soles in india. |
American MNCs own a high proportion of certain widely used drugs and formulations. US market share is: antibiotics, 42%; antibacterials, 98%; car-diovasculors, 51 %, and anti-Ieprosy drugs, 70%. |
|
MNCs can claim they are "warking" palents in India by imparting the praducls from the productian cenn. This will resulr in the domestic market being served entirely by imparts. |
Negotiations are in progress to ensure that if a potent is not worked within the country, the patent- holder will hove to license production compulsorily to an indian associate. |
Delails of negotiations are not available. |
|
DO provisions require a minimum 20-year validity period for a patent. The Indian Patents Act limits thisto 7-14 years. |
There is international consensus on the 2O-year period. |
The Indian government must specify its sland. |
|
A patent"s validity period can be increased manifold under DD provisions because they demand s |
